Signaling diversity of mu- and delta- opioid receptor ligands: Re-evaluating the benefits of β-arrestin/G protein signaling bias
Authors:
Open Access
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 80, 109906
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
This publication has 99 references indexed in Scilit:
- Endomorphin-2: A Biased Agonist at the μ-Opioid ReceptorMolecular Pharmacology, 2012
- Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopyProceedings of the National Academy of Sciences, 2012
- A Simple Method for Quantifying Functional Selectivity and Agonist BiasACS Chemical Neuroscience, 2012
- Quantifying Ligand Bias at Seven-Transmembrane ReceptorsMolecular Pharmacology, 2011
- Multiple ligand-specific conformations of the β2-adrenergic receptorNature Chemical Biology, 2011
- Quantitative Encoding of the Effect of a Partial Agonist on Individual Opioid Receptors by Multisite Phosphorylation and Threshold DetectionScience Signaling, 2011
- Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysisBMC Genomics, 2011
- μ-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate InternalizationMolecular Pharmacology, 2010
- Morphine-like Opiates Selectively Antagonize Receptor-Arrestin InteractionsJournal of Biological Chemistry, 2010
- Calmodulin-Stimulated Adenylyl Cyclase Gene Deletion Affects Morphine ResponsesMolecular Pharmacology, 2006